Print this page
Myasthenia Gravis Own Your Copy Today

The acquired form of myasthenia gravis occurs in dogs and rarely in goats and cats. Affected animals produce autoantibodies to acetylcholine receptors, which bind to the receptor and reduce acetylcholine. The clinical manifestations mimic those produced by curare. Extreme generalized muscle weakness, accentuated by mild exercise, is common. Megaesophagus is a frequent primary or accompanying complaint in dogs. Thymomas are often associated with myasthenia gravis in humans, but this is uncommon in other animals. Administration of a short-acting anticholinesterase (edrophonium chloride) produces a dramatic increase in muscle strength. Treatment is with a long-acting anticholinesterase. Chronic immunosuppressive drug therapy for this disease is logical and should be investigated. Autoantibodies to the acetylcholine receptors can be detected in the serum of affected animals by an indirect immunohistopathologic analysis using normal muscle as a substrate.

See Also
Introduction
Diseases Involving Anaphylactic Reactions
Overview
Systemic Anaphylaxis
Localized Anaphylactic Reactions
Diseases Involving Cytotoxic Antibodies
Autoimmune Hemolytic Anemia and Thrombocytopenia
Autoimmune Skin Disorders
Diseases Involving Immune Complexes
Diseases Involving Cell-mediated Immunity
Immune-deficiency Diseases
Overview
Deficiencies in Phagocytosis
Leukocyte Adhesion Deficiency
Deficiencies in Immunoglobulins
Deficiencies in Cell-mediated Immunity
Combined Immunodeficiency Disease
Complement Deficiencies
Selective Immunodeficiencies
Viral-induced Immunodeficiencies
Tumors of the Immune System
Gammopathies